Zusammenfassung
Amyloide sind in der Natur weit verbreitete Proteinaggregate mit teils krankheitsauslösenden, vielfach aber auch wichtigen biologischen Funktionen. Obwohl die Ultrastruktur von Amyloid extrem konserviert ist, bleibt der Mechanismus der Amyloidogenese weiterhin ein komplexes Forschungsfeld. Beim Menschen können Amyloidosen primär in der Haut entstehen oder diese sekundär betreffen. Eine akkurate Diagnostik ist entscheidend für die Therapieplanung dieser heterogenen Gruppe an Krankheitsentitäten. Daher gibt diese Arbeit zunächst eine Übersicht über die verschiedenen Formen der Amyloidosen, um dann auf Diagnostik und mögliche Therapieoptionen einzugehen. Weiterhin wird die Unterscheidung zwischen funktionellen und krankheitsauslösenden Amyloiden vorgestellt.
Abstract
Amyloids are common protein aggregates in nature. Some amyloids fulfill important biological tasks while others are known to cause diseases. Despite the fact that the ultrastructure of amyloid is highly conserved, the mechanism of amyloidogenesis remains a challenging research topic. In humans, amyloidoses may develop in the skin or lead to skin signs due to secondary cutaneous involvement. An accurate diagnostic procedure is crucial for planning the therapy of this heterogeneous group of diseases. Therefore, the aim of this paper is to give an overview on the different kinds of amyloidoses as well as on diagnostic and therapeutic approaches. Furthermore, the discrimination between functional and disease-causing amyloid is briefly presented.
Literatur
Albers SE, Fenske NA, Glass LF et al (1994) Atypical beta 2-microglobulin amyloidosis following short-term hemodialysis. Am J Dermatopathol 16:179–184
Alster TS, Manaloto RM (1999) Nodular amyloidosis treated with a pulsed dye laser. Dermatol Surg 25:133–135
Alvarez-Lobos M, Hunter B, Cofre C et al (2006) Tumor necrosis factor receptor associated periodic syndrome (TRAPS). Report of two cases. Rev Med Chil 134:1558–1561
Arbustini E, Verga L, Concardi M et al (2002) Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 9:108–114
Arita K, South AP, Hans-Filho G et al (2008) Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 82:73–80
Babilas P, Fiebig BS, Aslanidis C et al (2009) Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis. Br J Dermatol 161:944–947
Badtke MP, Hammer ND, Chapman MR (2009) Functional amyloids signal their arrival. Sci Signal 2:pe43
Bellotti V, Chiti F (2008) Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 18:771–779
Bhak G, Choe YJ, Paik SR (2009) Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep 42:541–551
Bozikov K, Janezic T (2006) Excision and split thickness skin grafting in the treatment of nodular primary localized cutaneous amyloidosis. Eur J Dermatol 16:315–316
Breathnach SM (1988) Amyloid and amyloidosis. J Am Acad Dermatol 18:1–16
Breathnach SM, Hintner H (1990) Amyloid P-component and the skin. Clin Dermatol 8:46–54
Brownstein MH, Helwig EB (1971) Secondary systemic amyloidosis: analysis of underlying disorders. South Med J 64:491–496
Das J, Gogoi RK (2003) Treatment of primary localised cutaneous amyloidosis with cyclophosphamide. Indian J Dermatol Venereol Leprol 69:163–164
Eder L, Bitterman H (2007) Image in clinical medicine. Amyloid purpura. N Engl J Med 356:2406
Eisenberg D, Nelson R, Sawaya MR et al (2006) The structural biology of protein aggregation diseases: fundamental questions and some answers. Acc Chem Res 39:568–575
Elimova E, Kisilevsky R, Ancsin JB (2009) Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J 23:3436–3448
Ellis RJ, Minton AP (2006) Protein aggregation in crowded environments. Biol Chem 387:485–497
Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid–from bacteria to humans. Trends Biochem Sci 32:217–224
Gebbink MF, Claessen D, Bouma B et al (2005) Amyloids – a functional coat for microorganisms. Nat Rev Microbiol 3:333–341
Gerard S, Goff B le, Maugars Y et al (2007) Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra. Joint Bone Spine 74:659
Glenner GG (1981) The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Prog Histochem Cytochem 13:1–37
Guo Z, Eisenberg D (2008) The structure of a fibril-forming sequence, NNQQNY, in the context of a globular fold. Protein Sci 17:1617–1623
Hammer ND, Wang X, McGuffie BA, Chapman MR (2008) Amyloids: friend or foe? J Alzheimers Dis 13:407–419
Hashimoto K, Ito K, Taniguchi Y et al (1990) Keratin in cutaneous amyloidoses. Clin Dermatol 8:55–65
Hernandez-Nunez A, Dauden E, Moreno de Vega MJ et al (2001) Widespread biphasic amyloidosis: response to acitretin. Clin Exp Dermatol 26:256–259
Hobbs JR, Morgan AD (1963) Fluorescence microscopy with Thioflavine-T in the Diagnosis of amyloid. J Pathol Bacteriol 86:437–442
Iconomidou VA, Hamodrakas SJ (2008) Natural protective amyloids. Curr Protein Pept Sci 9:291–309
Inge-Vechtomov SG, Zhouravleva GA, Chernoff YO (2007) Biological roles of prion domains. Prion 1:228–235
Kimberley FC, Lobito AA, Siegel RM, Screaton GR (2007) Falling into TRAPS–receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 9:217
Kiuru-Enari S, Keski-Oja J, Haltia M (2005) Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol 152:250–257
Kumakiri M, Hashimoto K (1979) Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 73:150–162
Landa G, Aloni E, Milshtein A et al (2004) Eyelid bleeding and atypical amyloidosis. Am J Ophthalmol 138:495–496
Li WM (1990) Histopathology of primary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol 8:30–35
Lien MH, Railan D, Nelson BR (1997) The efficacy of dermabrasion in the treatment of nodular amyloidosis. J Am Acad Dermatol 36:315–316
Love WE, Miedler JD, Smith MK et al (2008) The spectrum of primary cutaneous nodular amyloidosis: Two illustrative cases. J Am Acad Dermatol 58:S33–S35
Lundmark K, Westermark GT, Olsen A, Westermark P (2005) Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci U S A 102:6098–6102
MacDonald DM, Black MM (1980) Secondary localized cutaneous amyloidosis in melanocytic naevi. Br J Dermatol 103:553–556
Maji SK, Perrin MH, Sawaya MR et al (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325:328–332
Maji SK, Wang L, Greenwald J, Riek R (2009) Structure-activity relationship of amyloid fibrils. FEBS Lett 583:2610–2617
Malak JA, Smith EW (1962) Secondary localized cutaneous amyloidosis. Arch Dermatol 86:465–477
Maurer-Stroh S, Debulpaep M, Kuemmerer N et al (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7:237–242
McGlinchey RP, Shewmaker F, McPhie P et al (2009) The repeat domain of the melanosome fibril protein Pmel17 forms the amyloid core promoting melanin synthesis. Proc Natl Acad Sci U S A 106:13731–13736
Meretoja J (1969) Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1:314–324
Mirault T, Launay D, Cuisset L et al (2006) Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 54:1697–1700
Muckle TJ (1979) The „Muckle-Wells“ syndrome. Br J Dermatol 100:87–92
Nelson R, Sawaya MR, Balbirnie M et al (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773–778
Ollague W, Ollague J, Ferretti H (1990) Epidemiology of primary cutaneous amyloidoses in South America. Clin Dermatol 8:25–29
Pandhi R, Kaur I, Kumar B (2002) Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat 13:11–14
Park J, Kahng B, Hwang W (2009) Thermodynamic selection of steric zipper patterns in the amyloid cross-beta spine. PLoS Comput Biol 5:e1000492
Powell AM, Albert S, Bhogal B, Black MM (2005) Discoid lupus erythematosus with secondary amyloidosis. Br J Dermatol 153:746–749
Raap U, Kapp A, Wedi B, Stander S (2010) Pruritus and urticaria. Hautarzt 61:737–742
Ramsook CB, Tan C, Garcia MC et al (2010) Yeast cell adhesion molecules have functional amyloid-forming sequences. Eukaryot Cell 9:393–404
Rubinow A, Cohen AS (1981) Skin involvement in familial amyloidotic polyneuropathy. Neurology 31:1341–1345
Ruzicka T, Donhauser G, Linke RP et al (1990) Cutaneous amyloidoses. Hautarzt 41:245–255
Sawaya MR, Sambashivan S, Nelson R et al (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453–457
Schreml S, Kaiser E, Szeimies RM et al (2010) Amyloid in skin and brain: what’s the link? Exp Dermatol [Epub ahead of print]
Schreml S, Szeimies RM, Vogt T et al (2010) Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol 20:152–160
Shirahama T, Cohen AS (1965) Structure of amyloid fibrils after negative staining and high-resolution electron microscopy. Nature 206:737–738
Sidwell RU, Francis N, Roberts NM, Staughton RC (2002) Allotropic cutaneous amyloidosis: coincidence or progression? Clin Exp Dermatol 27:526–528
Tan T (1990) Epidemiology of primary cutaneous amyloidoses in southeast Asia. Clin Dermatol 8:20–24
Truhan AP, Garden JM, Roenigk HH Jr (1986) Nodular primary localized cutaneous amyloidosis: immunohistochemical evaluation and treatment with the carbon dioxide laser. J Am Acad Dermatol 14:1058–1062
Vestey JP, Tidman MJ, McLaren KM (1994) Primary nodular cutaneous amyloidosis – long-term follow-up and treatment. Clin Exp Dermatol 19:159–162
Virchow R (1854) Zur Cellulose-Frage. Virchows Archiv Pathol Anat Physiol Klin Med 8:416–426
von Rokitansky C (1842) Handbuch der pathologischen Anatomie. 3:311
Wall JS, Gupta V, Wilkerson M et al (2004) Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. J Mol Recognit 17:323–331
Wang WJ, Lin CS, Wong CK (1986) Response of systemic amyloidosis to dimethyl sulfoxide. J Am Acad Dermatol 15:402–405
Wang X, Zhou Y, Ren JJ et al (2010) Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A 107:163–168
Westermark P, Davey E, Lindbom K, Enqvist S (2006) Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem 108:209–213
Zhang Q, Putheti P, Zhou Q et al (2008) Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 19:347–356
Zhang Z, Chen H, Lai L (2007) Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23:2218–2225
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schreml, S., Szeimies, RM., Landthaler, M. et al. Kutane Amyloidosen. Hautarzt 62, 55–62 (2011). https://doi.org/10.1007/s00105-010-2073-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-010-2073-x